Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
29185 | 191 | 19.5 | 41% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
522 | 3 | MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM | 20526 |
2418 | 2 | HYDROCHLOROTHIAZIDE//CICLETANINE//TORASEMIDE | 4143 |
29185 | 1 | CHERRY SYRUP//SUSPENDING AGENTS//CHOLELITHOLYTIC AGENTS | 191 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHERRY SYRUP | authKW | 652803 | 4% | 58% | 7 |
2 | SUSPENDING AGENTS | authKW | 373024 | 4% | 33% | 7 |
3 | CHOLELITHOLYTIC AGENTS | authKW | 319743 | 1% | 100% | 2 |
4 | SWEETENING AGENTS | authKW | 252689 | 4% | 23% | 7 |
5 | ACETAZOLAMIDE ACZ | authKW | 213161 | 1% | 67% | 2 |
6 | INCOMPATIBILITIES | authKW | 165737 | 8% | 7% | 15 |
7 | ACETAZOLAMIDE INTOXICATION | authKW | 159871 | 1% | 100% | 1 |
8 | ADHERENCE MARKER | authKW | 159871 | 1% | 100% | 1 |
9 | AGE APPROPRIATE FORMULATION | authKW | 159871 | 1% | 100% | 1 |
10 | ANCOTIL R INTRAVENOUS SOLUTION | authKW | 159871 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 2867 | 70% | 0% | 134 |
2 | Chemistry, Medicinal | 286 | 12% | 0% | 23 |
3 | Ophthalmology | 234 | 10% | 0% | 19 |
4 | Chemistry, Analytical | 67 | 9% | 0% | 18 |
5 | Chemistry, Multidisciplinary | 10 | 8% | 0% | 15 |
6 | Pediatrics | 7 | 3% | 0% | 6 |
7 | Electrochemistry | 2 | 2% | 0% | 3 |
8 | Health Care Sciences & Services | 2 | 1% | 0% | 2 |
9 | Gerontology | 1 | 1% | 0% | 1 |
10 | Medicine, General & Internal | 1 | 3% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LONDON SOUTH EAST NIHR MED CHILDREN LOCAL N | 159871 | 1% | 100% | 1 |
2 | MATER CHILDRENS EMERGENCY | 159871 | 1% | 100% | 1 |
3 | PHARMACEUT DEV EXPT STN | 159871 | 1% | 100% | 1 |
4 | RAKCOPS | 159871 | 1% | 100% | 1 |
5 | SOUL PATTINSON SDN BHD | 159871 | 1% | 100% | 1 |
6 | THER IES MED CONSEQUENCES | 159871 | 1% | 100% | 1 |
7 | UMI ST GOBAIN 3629 | 159871 | 1% | 100% | 1 |
8 | PROC SERV QUAL | 79935 | 1% | 50% | 1 |
9 | WEXNER PEDIAT | 63941 | 2% | 10% | 4 |
10 | BIOMOL ORGAN SYNTH | 53289 | 1% | 33% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 23407 | 12% | 1% | 23 |
2 | DISSOLUTION TECHNOLOGIES | 19487 | 3% | 2% | 5 |
3 | AMERICAN JOURNAL OF HOSPITAL PHARMACY | 16908 | 8% | 1% | 16 |
4 | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 2957 | 5% | 0% | 10 |
5 | JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES | 2076 | 2% | 0% | 3 |
6 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1966 | 7% | 0% | 14 |
7 | JOURNAL OF PHARMACEUTICAL SCIENCES | 1145 | 5% | 0% | 9 |
8 | JOURNAL OF GENERAL MANAGEMENT | 1036 | 1% | 1% | 1 |
9 | ANNALS OF PHARMACOTHERAPY | 736 | 3% | 0% | 5 |
10 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 707 | 4% | 0% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHERRY SYRUP | 652803 | 4% | 58% | 7 | Search CHERRY+SYRUP | Search CHERRY+SYRUP |
2 | SUSPENDING AGENTS | 373024 | 4% | 33% | 7 | Search SUSPENDING+AGENTS | Search SUSPENDING+AGENTS |
3 | CHOLELITHOLYTIC AGENTS | 319743 | 1% | 100% | 2 | Search CHOLELITHOLYTIC+AGENTS | Search CHOLELITHOLYTIC+AGENTS |
4 | SWEETENING AGENTS | 252689 | 4% | 23% | 7 | Search SWEETENING+AGENTS | Search SWEETENING+AGENTS |
5 | ACETAZOLAMIDE ACZ | 213161 | 1% | 67% | 2 | Search ACETAZOLAMIDE+ACZ | Search ACETAZOLAMIDE+ACZ |
6 | INCOMPATIBILITIES | 165737 | 8% | 7% | 15 | Search INCOMPATIBILITIES | Search INCOMPATIBILITIES |
7 | ACETAZOLAMIDE INTOXICATION | 159871 | 1% | 100% | 1 | Search ACETAZOLAMIDE+INTOXICATION | Search ACETAZOLAMIDE+INTOXICATION |
8 | ADHERENCE MARKER | 159871 | 1% | 100% | 1 | Search ADHERENCE+MARKER | Search ADHERENCE+MARKER |
9 | AGE APPROPRIATE FORMULATION | 159871 | 1% | 100% | 1 | Search AGE+APPROPRIATE+FORMULATION | Search AGE+APPROPRIATE+FORMULATION |
10 | ANCOTIL R INTRAVENOUS SOLUTION | 159871 | 1% | 100% | 1 | Search ANCOTIL+R+INTRAVENOUS+SOLUTION | Search ANCOTIL+R+INTRAVENOUS+SOLUTION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GLASS, BD , HAYWOOD, A , (2006) STABILITY CONSIDERATIONS IN LIQUID DOSAGE FORMS EXTEMPORANEOUSLY PREPARED FROM COMMERCIALLY AVAILABLE PRODUCTS..JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. VOL. 9. ISSUE 3. P. 398-426 | 36 | 34% | 25 |
2 | SCHWENK, MH , STPETER, WL , MEESE, MG , SINGHAL, PC , (1995) ACETAZOLAMIDE TOXICITY AND PHARMACOKINETICS IN PATIENTS RECEIVING HEMODIALYSIS.PHARMACOTHERAPY. VOL. 15. ISSUE 4. P. 522-527 | 13 | 87% | 8 |
3 | TAFT, DR , NORDT, S , IYER, GR , SCHWENK, MH , (1998) BLOOD DISPOSITION AND URINARY EXCRETION KINETICS OF METHAZOLAMIDE FOLLOWING ORAL ADMINISTRATION TO HUMAN SUBJECTS.BIOPHARMACEUTICS & DRUG DISPOSITION. VOL. 19. ISSUE 6. P. 373-380 | 10 | 91% | 3 |
4 | ICHIKAWA, N , NAORA, K , HIRANO, H , IWAMOTO, K , (1998) QUANTITATION OF ACETAZOLAMIDE IN RAT PLASMA, BRAIN TISSUE AND CEREBROSPINAL FLUID BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 17. ISSUE 8. P. 1415-1421 | 8 | 100% | 13 |
5 | YUE, CS , HUYNH, HH , RAYMOND, C , CHARBONNEAU, L , ROY, L , (2013) POPULATION PHARMACOKINETIC AND PHARMACODYNAMIC MODELING OF ACETAZOLAMIDE IN PERITONEAL DIALYSIS PATIENTS AND HEALTHY VOLUNTEERS.JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. VOL. 16. ISSUE 1. P. 89-98 | 9 | 56% | 1 |
6 | BREVEDAN, MIV , VARILLAS, MA , VIDAL, NLG , (2012) DISSOLUTION STABILITY OF CEPHALEXIN EXTEMPORANEOUS SUSPENSIONS DURING AN ACCELERATED STABILITY STUDY.DISSOLUTION TECHNOLOGIES. VOL. 19. ISSUE 3. P. 23-27 | 7 | 70% | 1 |
7 | YANO, I , TAKAYAMA, A , TAKANO, M , INATANI, M , TANIHARA, H , OGURA, Y , HONDA, Y , INUI, K , (1998) PHARMACOKINETICS AND PHARMACODYNAMICS OF ACETAZOLAMIDE IN PATIENTS WITH TRANSIENT INTRAOCULAR PRESSURE ELEVATION.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 54. ISSUE 1. P. 63-68 | 7 | 100% | 16 |
8 | ALLEN, LV , ERICKSON, MA , (1996) STABILITY OF LABETALOL HYDROCHLORIDE, METOPROLOL TARTRATE, VERAPAMIL HYDROCHLORIDE, AND SPIRONOLACTONE WITH HYDROCHLOROTHIAZIDE IN EXTEMPORANEOUSLY COMPOUNDED ORAL LIQUIDS.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 53. ISSUE 19. P. 2304 -2309 | 8 | 89% | 7 |
9 | SRINIVASU, P , SUBBARAO, DV , VEGESNA, RVK , BABU, KS , (2010) A VALIDATED STABILITY-INDICATING LC METHOD FOR ACETAZOLAMIDE IN THE PRESENCE OF DEGRADATION PRODUCTS AND ITS PROCESS-RELATED IMPURITIES.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 52. ISSUE 1. P. 142-148 | 6 | 75% | 7 |
10 | ALLEN, LV , ERICKSON, MA , (1998) STABILITY OF ALPRAZOLAM, CHLOROQUINE PHOSPHATE, CISAPRIDE, ENALAPRIL MALEATE, AND HYDRALAZINE HYDROCHLORIDE IN EXTEMPORANEOUSLY COMPOUNDED ORAL LIQUIDS.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 55. ISSUE 18. P. 1915-1920 | 8 | 80% | 14 |
Classes with closest relation at Level 1 |